Back to HCC home

Text size

Large / Normal

Contact info

Corporate Communications Fax
(860) 224-5779

Both campuses
(860) 224-5695

Other info

Press release details

Hospital’s cancer program awarded accreditation with commendation

New Bri [May 12 2009] - The American College of Surgeons (ACOS) Commission on Cancer has awarded The Hospital of Central Connecticut (HCC) a three-year accreditation with commendation as a Teaching Hospital Cancer Program.

In April, an ACOS physician surveyor conducted an extensive evaluation of HCC’s cancer services, including a review of 36 standards required for program accreditation. HCC received commendations for five standards reviewed.

“The three-year approval by the American College of Surgeons Commission on Cancer demonstrates the continuing excellence of the cancer program at The Hospital of Central Connecticut. This is a designation awarded to only a handful of hospitals in Connecticut,” says Peter D. Byeff, M.D., director of the George Bray Cancer Center.

“This accreditation is also reflective of the strong commitment and compassion of hospital staff members who work as a team in caring for cancer patients in our community,” says Denise Peterson, R.N., M.S., director of Oncology Services.

Commendations recognized the hospital’s cancer outcomes analysis through its annual reports; quality of data reported to the National Cancer Data Base; 100 percent compliance with College of American Pathologists’ requirements; offering three or more prevention or early detection programs; and cancer-related improvements, namely survival studies related to pancreatic cancer and malignant brain tumors.

HCC provides comprehensive care for a variety of cancers and is currently planning to build a comprehensive cancer center to augment the hospital’s current services. These include diagnostic procedures, including MRI, CT, PET and PET-CT scanning; chemotherapy; radiation therapy, including intensity modulated radiation therapy (IMRT), brachytherapy and Novalis radiosurgery; surgical oncology for esophageal, colorectal, thoracic, breast and neurological cancers; hematology and gynecologic oncology; clinical trials to test new medications and treatments; and support services for patients and their loved ones/caregivers.

Contact: Kimberly Gensicki, 860-224-5900, x6507

HCC Corporate Communications
(860) 224-5695 • Fax (860) 224-5779